Trophoblastic disease.
Tomoda
Y
Y
Ishizuka
T
T
Goto
S
S
Furuhashi
Y
Y
D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy; D002822:Choriocarcinoma / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005260:Female; D006728:Hormones / Q000378:metabolism; D006801:Humans; D006828:Hydatidiform Mole / Q000453:epidemiology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D002820:Hydatidiform Mole, Invasive / Q000401:mortality / Q000473:pathology / Q000628:therapy; D015994:Incidence; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy; D011247:Pregnancy; D011379:Prognosis; D015996:Survival Rate; D014328:Trophoblastic Neoplasms / Q000145:classification / Q000473:pathology; D014594:Uterine Neoplasms / Q000145:classification / Q000473:pathology
D006728:Hormones